| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.01uM, 5-fluoro-2-(2-fluoro-4-methylsulfanylanilino)-N-[(2S)-2-hydroxypropoxy]-1-methyl-6-oxopyridine-3-carboxamide, Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Inhibitors of Signal Transduction Pathways targeting MAP2K7 (Novartis, 16666652) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/16666652 |
| Similar Terms | |
| Downloads & Tools |
1 genes differentially expressed following the BC-33-BM51_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 1.13105 |